Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents
Mousumi Pal, Utpal Nandi, Debaraj Mukherjee
European Journal of Medicinal Chemistry (2018) Vol. 150, pp. 419-445
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Enzo Alessio, Luigi Messori
Molecules (2019) Vol. 24, Iss. 10, pp. 1995-1995
Open Access | Times Cited: 315
Metal Drugs and the Anticancer Immune Response
Bernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1519-1624
Open Access | Times Cited: 307
Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
Ke Lin, Zizhuo Zhao, Huaben Bo, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 139
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity
Claudia Riccardi, Domenica Musumeci, Marco Trifuoggi, et al.
Pharmaceuticals (2019) Vol. 12, Iss. 4, pp. 146-146
Open Access | Times Cited: 80
Target based chemotherapeutic advancement of ruthenium complexes
Pragti Pragti, Bidyut Kumar Kundu, Suman Mukhopadhyay
Coordination Chemistry Reviews (2021) Vol. 448, pp. 214169-214169
Closed Access | Times Cited: 80
Piano stool Ru(II)-arene complexes having three monodentate legs: A comprehensive review on their development as anticancer therapeutics over the past decade
Srividya Swaminathan, Jebiti Haribabu, Nithya Balakrishnan, et al.
Coordination Chemistry Reviews (2022) Vol. 459, pp. 214403-214403
Closed Access | Times Cited: 61
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
Maria Grazia Ferraro, Marialuisa Piccolo, Gabriella Misso, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 954-954
Open Access | Times Cited: 56
An overview on the anticancer activity of Ru(II)/acylthiourea complexes
Gabriel H. Ribeiro, Analu R. Costa, Aparecido Ribeiro de Souza, et al.
Coordination Chemistry Reviews (2023) Vol. 488, pp. 215161-215161
Closed Access | Times Cited: 37
Exploring the Future of Metal‐Based Anticancer Agents: A Comprehensive Review of Ruthenium‐Based Complexes
Syamal D. Bhattacharya, Tenzin Adon, Karen M. DSouza, et al.
ChemistrySelect (2025) Vol. 10, Iss. 9
Closed Access | Times Cited: 1
Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity
Miriama Šimunková, Peter Lauro, Klaudia Jomová, et al.
Journal of Inorganic Biochemistry (2019) Vol. 194, pp. 97-113
Closed Access | Times Cited: 76
Selenium-containing ruthenium complex synergizes with natural killer cells to enhance immunotherapy against prostate cancer via activating TRAIL/FasL signaling
Haoqiang Lai, Delong Zeng, Chang Liu, et al.
Biomaterials (2019) Vol. 219, pp. 119377-119377
Closed Access | Times Cited: 76
RuII(p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo
Oscar A. Lenis-Rojas, M. Paula Robalo, Ana Isabel Tomaz, et al.
Inorganic Chemistry (2018) Vol. 57, Iss. 21, pp. 13150-13166
Closed Access | Times Cited: 66
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer
Marialuisa Piccolo, Gabriella Misso, Maria Grazia Ferraro, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 57
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem
Maria Grazia Ferraro, Marco Bocchetti, Claudia Riccardi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6473-6473
Open Access | Times Cited: 17
Novel lawsone-containing ruthenium(II) complexes: Synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells
Rone Aparecido De Grandis, Patrick Santos, Katia M. Oliveira, et al.
Bioorganic Chemistry (2019) Vol. 85, pp. 455-468
Closed Access | Times Cited: 49
Multifunctional, heterometallic ruthenium-platinum complexes with medicinal applications
Avijita Jain
Coordination Chemistry Reviews (2019) Vol. 401, pp. 213067-213067
Closed Access | Times Cited: 44
Dichloro Ru(II)-p-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case Study
Srividya Swaminathan, Ramasamy Karvembu
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 7, pp. 982-996
Closed Access | Times Cited: 15
Revolutionizing anticancer treatment: Ruthenium-based nanoplatforms pave new paths
Dipanjan Karati, Shreyasi Meur, Swarupananda Mukherjee, et al.
Coordination Chemistry Reviews (2024) Vol. 519, pp. 216118-216118
Closed Access | Times Cited: 6
Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]2+ co-targeting drug resistant GRP78 and subcellular organelles in cancer stem cells
Baskaran Purushothaman, Parthasarathy Arumugam, Hee Young Ju, et al.
European Journal of Medicinal Chemistry (2018) Vol. 156, pp. 747-759
Closed Access | Times Cited: 42
Self-assembled ruthenium (II) metallacycles and metallacages with imidazole-based ligands and their in vitro anticancer activity
Yibo Zhao, Liqian Zhang, Xu Li, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 10, pp. 4090-4098
Open Access | Times Cited: 40
In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes
Vivianne S. Velozo-Sá, Luciano R. Pereira, Aliny Pereira de Lima, et al.
Dalton Transactions (2019) Vol. 48, Iss. 18, pp. 6026-6039
Closed Access | Times Cited: 36
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems
Maria Grazia Ferraro, Marialuisa Piccolo, Gabriella Misso, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1412-1412
Open Access | Times Cited: 34
Heterodinuclear Ru–Pt Complexes Bridged with 2,3-Bis(pyridyl)pyrazinyl Ligands: Studies on Kinetics, Deoxyribonucleic Acid/Bovine Serum Albumin Binding and Cleavage, In Vitro Cytotoxicity, and In Vivo Toxicity on Zebrafish Embryo Activities
Rajesh Bellam, Deogratius Jaganyi, Ross S. Robinson
ACS Omega (2022) Vol. 7, Iss. 30, pp. 26226-26245
Open Access | Times Cited: 20
Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction
Gabriel H. Ribeiro, Adriana P. M. Guedes, Tamires D. de Oliveira, et al.
Inorganic Chemistry (2020) Vol. 59, Iss. 20, pp. 15004-15018
Closed Access | Times Cited: 31
Metal complexes of β-carboline: Advances in anticancer therapeutics
Yusuf Oloruntoyin Ayipo, Wahab Adesina Osunniran, Mohd Nizam Mordi
Coordination Chemistry Reviews (2021) Vol. 432, pp. 213746-213746
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top